RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

Arnab Chakravarti; Meihua Wang; H. Ian Robins; Tim Lautenschlaeger; Walter J. Curran; David G. Brachman; Christopher J. Schultz; Ali Choucair; Marisa Dolled-Filhart; Jason Christiansen; Mark Gustavson; Annette Molinaro; Paul Mischel; Adam P. Dicker; Markus Bredel; Minesh Mehta

doi:10.1016/j.ijrobp.2012.10.008

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

Arnab Chakravarti, Meihua Wang, H. Ian Robins, Tim Lautenschlaeger, Walter J. Curran, David G. Brachman, Christopher J. Schultz, Ali Choucair, Marisa Dolled-Filhart, Jason Christiansen, Mark Gustavson, Annette Molinaro, Paul Mischel, Adam P. Dicker, Markus Bredel, Minesh Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	International Journal of Radiation Oncology Biology Physics
Volume	85
DOIs	https://doi.org/10.1016/j.ijrobp.2012.10.008
State	Published - Jan 4 2013

Disciplines

Medicine and Health Sciences
Medical Biophysics

Access to Document

10.1016/j.ijrobp.2012.10.008License: Unspecified

Cite this

Chakravarti, A., Wang, M., Robins, H. I., Lautenschlaeger, T., Curran, W. J., Brachman, D. G., Schultz, C. J., Choucair, A., Dolled-Filhart, M., Christiansen, J., Gustavson, M., Molinaro, A., Mischel, P., Dicker, A. P., Bredel, M., & Mehta, M. (2013). RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. International Journal of Radiation Oncology Biology Physics, 85. https://doi.org/10.1016/j.ijrobp.2012.10.008

Chakravarti, A, Wang, M, Robins, HI, Lautenschlaeger, T, Curran, WJ, Brachman, DG, Schultz, CJ, Choucair, A, Dolled-Filhart, M, Christiansen, J, Gustavson, M, Molinaro, A, Mischel, P, Dicker, AP, Bredel, M & Mehta, M 2013, 'RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.', International Journal of Radiation Oncology Biology Physics, vol. 85. https://doi.org/10.1016/j.ijrobp.2012.10.008

@article{9bf744388d5b4cfaa88b8df32a932490,

title = "RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.",

author = "Arnab Chakravarti and Meihua Wang and Robins, \{H. Ian\} and Tim Lautenschlaeger and Curran, \{Walter J.\} and Brachman, \{David G.\} and Schultz, \{Christopher J.\} and Ali Choucair and Marisa Dolled-Filhart and Jason Christiansen and Mark Gustavson and Annette Molinaro and Paul Mischel and Dicker, \{Adam P.\} and Markus Bredel and Minesh Mehta",

year = "2013",

month = jan,

day = "4",

doi = "10.1016/j.ijrobp.2012.10.008",

language = "American English",

volume = "85",

journal = "International Journal of Radiation Oncology Biology Physics",

}

TY - JOUR

T1 - RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

AU - Chakravarti, Arnab

AU - Wang, Meihua

AU - Robins, H. Ian

AU - Lautenschlaeger, Tim

AU - Curran, Walter J.

AU - Brachman, David G.

AU - Schultz, Christopher J.

AU - Choucair, Ali

AU - Dolled-Filhart, Marisa

AU - Christiansen, Jason

AU - Gustavson, Mark

AU - Molinaro, Annette

AU - Mischel, Paul

AU - Dicker, Adam P.

AU - Bredel, Markus

AU - Mehta, Minesh

PY - 2013/1/4

Y1 - 2013/1/4

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199329/

U2 - 10.1016/j.ijrobp.2012.10.008

DO - 10.1016/j.ijrobp.2012.10.008

M3 - Article

VL - 85

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

ER -

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

Disciplines

Access to Document

Other files and links

Cite this